Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena; Cavo, Michele; Petrucci, Maria Teresa, Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight, «LEUKEMIA RESEARCH REPORTS», 2024, 21, Article number: 100399, pp. 1 - 4 [articolo]Open Access
Mina R.; Musto P.; Rota-Scalabrini D.; Paris L.; Gamberi B.; Palmas A.; Aquino S.; de Fabritiis P.; Giuliani N.; De Rosa L.; Gozzetti A.; Cellini C.; Bertamini L.; Capra A.; Oddolo D.; Vincelli I.D.; Ronconi S.; Pavone V.; Pescosta N.; Cea M.; Fioritoni F.; Ballanti S.; Grasso M.; Zamagni E.; Belotti A.; Boccadoro M.; Gay F., Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial, «THE LANCET ONCOLOGY», 2023, 24, pp. 64 - 76 [articolo]
Raab, Marc S.; Zamagni, Elena; Manier, Salomon; Rodriguez‐Otero, Paula; Schjesvold, Fredrik; Broijl, Annemiek, Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results, «EJHAEM», 2023, 4, pp. 1117 - 1131 [articolo]
Nanni, Cristina; Kobe, Carsten; Baeßler, Bettina; Baues, Christian; Boellaard, Ronald; Borchmann, Peter; Buck, Andreas; Buvat, Irène; Chapuy, Björn; Cheson, Bruce D; Chrzan, Robert; Cottereau, Ann-Segolene; Dührsen, Ulrich; Eikenes, Live; Hutchings, Martin; Jurczak, Wojciech; Kraeber-Bodéré, Françoise; Lopci, Egesta; Luminari, Stefano; MacLennan, Steven; Mikhaeel, N George; Nijland, Marcel; Rodríguez-Otero, Paula; Treglia, Giorgio; Withofs, Nadia; Zamagni, Elena; Zinzani, Pier Luigi; Zijlstra, Josée M; Herrmann, Ken; Kunikowska, Jolanta, European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours, «THE LANCET. HAEMATOLOGY», 2023, 10, pp. 381 - 381 [articolo]
Borsi E.; Mazzocchetti G.; Dico A.F.; Vigliotta I.; Martello M.; Poletti A.; Solli V.; Armuzzi S.; Taurisano B.; Kanapari A.; Pistis I.; Zamagni E.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.; Terragna C., High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients, «CLINICAL AND EXPERIMENTAL MEDICINE», 2023, 23, pp. 5227 - 5239 [articolo]Open Access
Zamagni E.; Oliva S.; Gay F.; Capra A.; Rota-Scalabrini D.; D'Agostino M.; Belotti A.; Galli M.; Racca M.; Zambello R.; Gamberi B.; Albano D.; Bertamini L.; Versari A.; Grasso M.; Sgherza N.; Priola C.; Fioritoni F.; Patriarca F.; De Cicco G.; Villanova T.; Pascarella A.; Zucchetta P.; Tacchetti P.; Fanti S.; Mancuso K.; Barbato S.; Boccadoro M.; Musto P.; Cavo M.; Nanni C., Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial, «ECLINICALMEDICINE», 2023, 60, Article number: 102017, pp. 1 - 13 [articolo]Open Access
Mancuso K.; Zamagni E.; Solli V.; Gabrielli L.; Leone M.; Pantani L.; Rocchi S.; Rizzello I.; Tacchetti P.; Ghibellini S.; Favero E.; Ursi M.; Talarico M.; Barbato S.; Kanapari A.; Bigi F.; Puppi M.; Terragna C.; Borsi E.; Martello M.; Poletti A.; Scata A.; Nepoti G.; Ruffini B.; Lazzarotto T.; Cavo M., Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma, «FRONTIERS IN ONCOLOGY», 2023, 13, Article number: 1208741, pp. 1 - 12 [articolo]Open Access
Pignatti, Marco; Dolci, Giampiero; Zamagni, Elena; Pascale, Renato; Piccin, Ottavio; Ammar, Alessandro; Zeneli, Flavia; Miralles, Maria Elisa Lozano; Mancuso, Katia; Cipriani, Riccardo; Viale, Pierluigi; Pacini, Davide; Martin-Suàrez, Sofia, Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature, «MICROORGANISMS», 2023, 11, Article number: 2699, pp. 1 - 12 [articolo]Open Access
Morvan L.; Nanni C.; Michaud A.-V.; Jamet B.; Bailly C.; Bodet-Milin C.; Chauvie S.; Touzeau C.; Moreau P.; Zamagni E.; Kraeber-Bodere F.; Carlier T.; Mateus D., Multiple Myeloma Prognosis From PET Images: Deep Survival Losses and Contrastive Pretraining, «IEEE TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES», 2023, 7, pp. 732 - 741 [articolo]
Kraeber-Bodere F.; Jamet B.; Bezzi D.; Zamagni E.; Moreau P.; Nanni C., New Developments in Myeloma Treatment and Response Assessment, «THE JOURNAL OF NUCLEAR MEDICINE», 2023, 64, pp. 1331 - 1343 [articolo]Open Access
Giovannamaria Petrocelli, Provvidenza Maria Abruzzo, Luca Pampanella, Riccardo Tassinari, Serena Marini, Martina Fazzina, Elena Zamagni, Carlo Ventura, Federica Facchin, Silvia Canaider, Oxytocin modulates osteogenic commitment in human adipose-derived mesenchymal stem cells, in: Abstract Book, 2023, pp. 165 - 166 (atti di: Second International StemNet meeting, Brescia, 18 - 19 - 20 ottobre 2023) [atti di convegno-abstract]
Petrocelli, Giovannamaria; Abruzzo, Provvidenza Maria; Pampanella, Luca; Tassinari, Riccardo; Marini, Serena; Zamagni, Elena; Ventura, Carlo; Facchin, Federica; Canaider, Silvia, Oxytocin Modulates Osteogenic Commitment in Human Adipose-Derived Stem Cells, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2023, 24, Article number: 10813, pp. 1 - 25 [articolo]Open Access
Annamaria Brioli; Laura Gengenbach; Katia Mancuso; Mascha Binder; Thomas Ernst; Florian H. Heidel; Thomas Stauch; Elena Zamagni; Inken Hilgendorf; Andreas Hochhaus; Monika Engelhardt; Marie von Lilienfeld-Toal, Pomalidomide combinations are a safe and effective option after daratumumab failure, «JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY», 2023, 149, pp. 6569 - 6574 [articolo]Open Access
Oliva S.; Genuardi E.; Paris L.; D'Agostino M.; Rogers J.; Rota-Scalabrini D.; Jacob A.P.; Patriarca F.; Luppi M.; Bertazzoni P.; Velluti C.; Capra A.; Saraci E.; Rossi M.; Allegra A.; Mina R.; Gentile M.; Kirsch I.R.; Belotti A.; Cavo M.; Bruno B.; Musto P.; Boccadoro M.; Zamagni E.; Gay F., Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing, «ECLINICALMEDICINE», 2023, 60, Article number: 102016, pp. 1 - 12 [articolo]Open Access
Kastritis E.; Terpos E.; Symeonidis A.; Labropoulou V.; Delimpasi S.; Mancuso K.; Zamagni E.; Katodritou E.; Rivolti E.; Kyrtsonis M.-C.; Roussou M.; Fotiou D.; Theodorakakou F.; Ntanasis-Stathopoulos I.; Hatjiharissi E.; Kanellias N.; Migkou M.; Cheliotis G.; Manousou K.; Gavriatopoulou M.; Dimopoulos M.A., Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study, «AMERICAN JOURNAL OF HEMATOLOGY», 2023, 98, pp. E226 - E229 [articolo]
